7.11.2024 16:44:22 CET | Ambu A/S |
Managers' Transactions
Pursuant to the Market Abuse Regulation, article 19, Ambu A/S hereby notifies receipt of information of the following transaction(s) made by persons discharging managerial responsibilities in Ambu A/S and/or their closely associated persons related to Ambu A/S’s shares admitted to trading and official listing on Nasdaq Copenhagen A/S.
The attached document discloses the data of the transactions made in Ambu shares.
Contacts
Anders Hjort, Head of Investor Relations, +45 2892 8881, anhj@ambu.com
Tine Bjørn Schmidt, Head of Corporate Communications, +45 2264 0697, tisc@ambu.com
About Ambu A/S
Since 1937, Ambu has been rethinking solutions, together with healthcare professionals, to save livesand improve patient care. Today, millions of patients and healthcare professionals worldwide depend on theefficiency, safety and performance of our single-use endoscopy, anaesthesia and patient monitoringsolutions. Headquartered near Copenhagen in Denmark, Ambu employs around 4,600 people in Europe, North America, Latin America and Asia Pacific.
For more information, please visit Ambu.com.
Attachments
Download announcement as PDF.pdf
07_11_2024 Michael del Prado.pdf
